The BCL2/BCL2L1 ratio was restored to the initial value in MOLT-16 and LOUCY cells but reduced in ALL-SIL (Figure 3E), further demonstrating that the BCL2/BCL2L1 ratio has limited applicability for venetoclax response prediction. This evidence concerns the gene BCL2 and acute lymphoblastic leukemia.